Severe pancytopenia triggered by recombinant hepatitis B vaccine

34Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We describe the case of a teenager who developed fever, arthritis, cutaneous vasculitis and severe pancytopenia 3 weeks after the third vaccination boost with a recombinant hepatitis B vaccine. Bone marrow examination showed paucity of late myeloid elements and, subsequently, maturation arrest. Interferon-γ (IFN-γ) production by peripheral blood mononuclear cells from the patient was dramatically increased. An underlying immune predisposition (HLA-DR3) may have indirectly enabled the vaccine to trigger a hepatitis B virus-specific cytotoxic T-lymphocyte response. It is therefore possible that the pancytopenia was induced by a dysregulation of the CD8+ T-cell compartment via increased IFN-γ production.

Cite

CITATION STYLE

APA

Viallard, J. F., Boiron, J. M., Parrens, M., Moreau, J. F., Ranchin, V., Reiffers, J., … Pellegrin, J. L. (2000). Severe pancytopenia triggered by recombinant hepatitis B vaccine. British Journal of Haematology, 110(1), 230–233. https://doi.org/10.1046/j.1365-2141.2000.02171.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free